Transitions of function and shape are key aspects of alveolar epithelial cell function during normal development as well as normal and abnormal interstitial remodeling. A major difficulty has been in defining methods and strategies for examining these transitions as they occur in vivo and in vitro. These transitions involve substantial changes in cell architecture which either lead to or are accompanied by changes in cell function such as surfactant production. We have targeted the cytoskeleton in our efforts to develop methods for studying alveolar epithelial cell structure-function relationships. We have, in particular, developed a unique panel of monoclonal antibodies against subclasses of the epithelial cell keratin intermediate filament proteins that appear to define epithelial cell transitions in the bleomycin model of fibrosis. Thus, we hypothesize that cytoskeletal protein undergo a change in isoform and organization as part of the process of changing shape and function. We plan to use these tools to study epithelial cell transitions during: 1) normal lung development; 2) during adult lung remodeling following pneumonectomy; 3) in two models of lung injury that appear to affect epithelial cells differentially, hyperoxia and bleomycin treatment; and 4) alveolar type II cells in culture. Our study will emphasize analysis of patterns of keratin antibody immunostaining at the light and electron microscope level. Parallel studies involving immunostaining and analyses of surfactant production will be carried out when the model and questions are appropriate. Studies of cells in culture or in specific substrate or matrix will be targeted at defining the relationship between epithelial cell shape and differentiated function. These experiments will answer fundamental questions regarding the nature of epithelial cell transitions in normal and pathologic tissue remodeling, as well as the relationship between shape and differentiated function of these cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
2P50HL014212-16
Application #
3943191
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Quinlan, T R; Marsh, J P; Janssen, Y M et al. (1994) Dose-responsive increases in pulmonary fibrosis after inhalation of asbestos. Am J Respir Crit Care Med 150:200-6
Roggli, V L; Coin, P G; MacIntyre, N R et al. (1994) Asbestos content of bronchoalveolar lavage fluid. A comparison of light and scanning electron microscopic analysis. Acta Cytol 38:502-10
Quinlan, T; Spivack, S; Mossman, B T (1994) Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 102 Suppl 2:79-87
Mossman, B T; Janssen, Y M; Marsh, J P et al. (1991) Development and characterization of a rapid-onset rodent inhalation model of asbestosis for disease prevention. Toxicol Pathol 19:412-8
Mossman, B T; Marsh, J P; Sesko, A et al. (1990) Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis 141:1266-71
Scott, S M; Buenaflor, G G; Orth, D N (1989) Immunoreactive human epidermal growth factor concentrations in amniotic fluid, umbilical artery and vein serum, and placenta in full-term and preterm infants. Biol Neonate 56:246-51
Ramage Jr, J E; Roggli, V L; Bell, D Y et al. (1988) Interstitial lung disease and domestic wood burning. Am Rev Respir Dis 137:1229-32
Fisher, G L; Mossman, B T; McFarland, A R et al. (1987) A possible mechanism of chrysotile asbestos toxicity. Drug Chem Toxicol 10:109-31
Mossman, B T; Gilbert, R; Doherty, J et al. (1986) Cellular and molecular mechanisms of asbestosis. Chest 89:160S-161S
Bell, D Y; Johnson, S M; Piantadosi, C A (1986) Elevated serum immunoglobulin G levels and bronchoalveolar lymphocytosis as predictors of clinical course in pulmonary sarcoidosis. Ann N Y Acad Sci 465:672-7

Showing the most recent 10 out of 11 publications